T&R Biofab Co., Ltd. (KOSDAQ:246710)

T&R Biofab Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Operating Revenue	26,967	4,874	5,199
Other Revenue	-	-	-0
Revenue	26,967	4,874	5,199
Revenue Growth (YoY)	453.32%	-6.26%	-
Cost of Revenue	20,139	2,766	4,151
Gross Profit	6,828	2,108	1,048
Selling, General & Admin	9,367	7,230	7,024
Research & Development	4,524	5,510	4,399
Amortization of Goodwill & Intangibles	265.87	83.77	61.8
Other Operating Expenses	285.72	172.15	227.69
Operating Expenses	15,496	15,407	13,902
Operating Income	-8,668	-13,299	-12,853
Interest Expense	-6,083	-3,071	-3.24
Interest & Investment Income	281.18	1,227	1,676
Currency Exchange Gain (Loss)	-32.59	7.49	0.97
Other Non Operating Income (Expenses)	-19,836	11,112	-1,424
EBT Excluding Unusual Items	-34,339	-4,023	-12,604
Gain (Loss) on Sale of Investments	1,474	-517.37	5.26
Gain (Loss) on Sale of Assets	72.86	-5.8	-0.14
Asset Writedown	-	-	-195.49
Other Unusual Items	-2,152	-3,133	-625.01
Pretax Income	-34,944	-7,679	-13,419
Net Income	-34,944	-7,679	-13,419
Net Income to Common	-34,944	-7,679	-13,419
Shares Outstanding (Basic)	32	26	25
Shares Outstanding (Diluted)	32	26	25
Shares Change (YoY)	23.66%	1.61%	-
EPS (Basic)	-1093.00	-297.00	-527.37
EPS (Diluted)	-1093.00	-297.00	-527.37
Free Cash Flow	-9,612	-14,309	-19,456
Free Cash Flow Per Share	-300.65	-553.45	-764.65
Gross Margin	25.32%	43.24%	20.16%
Operating Margin	-32.14%	-272.87%	-247.22%
Profit Margin	-129.58%	-157.56%	-258.10%
Free Cash Flow Margin	-35.64%	-293.60%	-374.22%
EBITDA	-3,635	-10,895	-10,697
EBITDA Margin	-13.48%	-223.55%	-205.74%
D&A For EBITDA	5,034	2,404	2,156
EBIT	-8,668	-13,299	-12,853
EBIT Margin	-32.14%	-272.87%	-247.22%
Advertising Expenses	375.67	390.07	267.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.